Arena Pharma (ARNA) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Price: $99.98 --0%
Financial Fact:
Net loss per share allocable to common stockholders, basic: -0.05
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Net loss per share allocable to common stockholders, basic: -0.05
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Arena Pharma (NASDAQ: ARNA) reported Q1 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $6.62 million versus the consensus estimate of $8.07 million.
For earnings history and earnings-related data on Arena Pharma (ARNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- JPMorgan Downgrades JD Logistics Inc (2618:HK) (JDLGF) to Neutral
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
